Targeted Genetics Corporation Form 8-K
Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) August 21, 2003

Targeted Genetics Corporation


(Exact name of registrant as specified in charter)
         
Washington   0-23930   91-1549568

(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)
     
1100 Olive Way, Suite 100, Seattle, Washington   98101

(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code (206) 623-7612

Not Applicable


(Former name or former address, if changed since last report)

1


TABLE OF CONTENTS

Item 7. Exhibits.
Item 12. Results and Operations of Financial Condition.
SIGNATURES
EXHIBIT INDEX
EXHIBIT 99.1


Table of Contents

Item 7. Exhibits.

  (a)   Financial statements of business acquired.
 
      Not applicable.
 
  (b)   Pro forma financial information.
 
      Not applicable.
 
  (c)   Exhibits.
     
Exhibit    
No.   Description

 
99.1   Press Release of Targeted Genetics Corporation dated August 21, 2003

Item 12. Results and Operations of Financial Condition.

     On August 21, 2003, Targeted Genetics Corporation issued a press release announcing the effectiveness of its registration statement on Form S-3. A copy of the press release is furnished as Exhibit 99.1 and is incorporated into this current report by reference.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    TARGETED GENETICS CORPORATION
         
         
Date: August 21, 2003   By:   /s/ H. STEWART PARKER
H. Stewart Parker
President and Chief Executive Officer
(Principal Executive Officer)

 


Table of Contents

EXHIBIT INDEX

     
Exhibit    
No.   Description

 
99.1   Press Release of Targeted Genetics Corporation dated August 21, 2003